date:Aug 01, 2018
ermits the sale of dietary supplement products containing cannabidiol if necessary by exercising its current rulemaking authority.
McGuffin added: This would allow FDA to more effectively regulate safety, quality and marketing claims under the comprehensive regulatory framework currently used for dietary supplement products in the U.S.
Others are skeptical HHS would choose to invoke its authority in the case of CBD. Even if the federal government received such a request, several sources with